Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nataliya Razumilava

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Hepatology|November 30, 2010
Combination of gemcitabine and cisplatin for biliary tract cancer: a platform to build onNataliya Razumilava, Gregory J Gores
Clinical Liver Disease|November 9, 2016
Surveillance for Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: Effective and Justified?Nataliya Razumilava, Gregory J Gores
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 18, 2012
Classification, diagnosis, and management of cholangiocarcinomaNataliya Razumilava, Gregory J Gores
Nature Genetics|August 28, 2015
Building a staircase to precision medicine for biliary tract cancerNataliya Razumilava, Gregory J Gores
Oncology (Williston Park, N.Y.)|May 10, 2011
Sorafenib for HCC: a pragmatic perspectiveNataliya Razumilava, Gregory J Gores
Lancet (London, England)|March 4, 2014
CholangiocarcinomaNataliya Razumilava, Gregory J Gores
Clinical Liver Disease|May 2, 2019
Vigilancia del colangiocarcinoma en pacientes con colangitis esclerosante primaria: ¿es efectiva y está justificada?Nataliya Razumilava, Gregory J Gores
Hepatology (Baltimore, Md.)|January 10, 2022
Corticosteroids for high-grade immune checkpoint inhibitor-mediated hepatitis: Is less more?Jason J Pan, Nataliya Razumilava
Lancet (London, England)|September 30, 2014
Liver transplantation for intrahepatic cholangiocarcinoma--Authors' replyNataliya Razumilava, Gregory J Gores
Journal of Hepatology|January 29, 2013
Notch-driven carcinogenesis: the merging of hepatocellular cancer and cholangiocarcinoma into a common molecular liver cancer subtypeNataliya Razumilava, Gregory J Gores
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Hepatology|November 30, 2010
Combination of gemcitabine and cisplatin for biliary tract cancer: a platform to build onNataliya Razumilava, Gregory J Gores
Clinical Liver Disease|November 9, 2016
Surveillance for Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: Effective and Justified?Nataliya Razumilava, Gregory J Gores
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 18, 2012
Classification, diagnosis, and management of cholangiocarcinomaNataliya Razumilava, Gregory J Gores
Nature Genetics|August 28, 2015
Building a staircase to precision medicine for biliary tract cancerNataliya Razumilava, Gregory J Gores
Oncology (Williston Park, N.Y.)|May 10, 2011
Sorafenib for HCC: a pragmatic perspectiveNataliya Razumilava, Gregory J Gores
Lancet (London, England)|March 4, 2014
CholangiocarcinomaNataliya Razumilava, Gregory J Gores
Clinical Liver Disease|May 2, 2019
Vigilancia del colangiocarcinoma en pacientes con colangitis esclerosante primaria: ¿es efectiva y está justificada?Nataliya Razumilava, Gregory J Gores
Hepatology (Baltimore, Md.)|January 10, 2022
Corticosteroids for high-grade immune checkpoint inhibitor-mediated hepatitis: Is less more?Jason J Pan, Nataliya Razumilava
Lancet (London, England)|September 30, 2014
Liver transplantation for intrahepatic cholangiocarcinoma--Authors' replyNataliya Razumilava, Gregory J Gores
Journal of Hepatology|January 29, 2013
Notch-driven carcinogenesis: the merging of hepatocellular cancer and cholangiocarcinoma into a common molecular liver cancer subtypeNataliya Razumilava, Gregory J Gores
Pageof 4